Should children exercise?

If you have a child of 6 to 8 years old that wants to start exercising and lifting weights, you may find yourself... Read More...

Cardio Exercise. Which one is better?

Everyone has wondered at some point in time which cardio exercise is better. To put it in simple terms, both low and... Read More...

Benefits of Boxing Training for Fitness

You may improve your health and have a physically fit body by getting into boxing training fitness programs. This is... Read More...

Seven Strategies For Fat Loss

Weight Training. Building lean body mass will speed up your bodys metablism. Muscle is active tissue, meaning it takes... Read More...

Tips to Help You Gain Weight

There are a couple of reasons why most people fail in their attempt to gain more muscle mass - improper diet and lack... Read More...

3 Bad Diet Mistakes To Avoid

Even though there is so much information available about weight loss, the same diet mistakes are being made over and... Read More...

Ways To Deal With Your Depression

Depression now affects 1 in 5 of the population, with most people using various types of medication. Most people would... Read More...

Teenagers and Depression: What Can We Do?

No doubt you have seen the recent news headlines about a federal panel that recommended to the FDA that anti-depressant... Read More...

Pregnancy Stages - week by week

There are three stages of pregnancy. These are the first, second and third trimesters. The first trimester runs from... Read More...

Weight Loss After Pregnancy

How fast you lose weight will depend on a number of factors, including the amount of weight you gained during your... Read More...

Showing page 1 of 9 pages

[First Page] [Prev] [Next] [Last Page]

IN THE HEADLINES

Merck Serono: Study Published In JCO Shows Erbitux Enhances Efficacy In MCRC Patients With KRAS Wild-Type Tumors In 1st-Line Setting A study published today in the Journal of Clinical Oncology demonstrates that the addition of Erbitux® (cetuximab) to standard oxaliplatin-based chemotherapy (FOLFOX-4) in previously untreated metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors results in significantly higher efficacy than chemotherapy alone. Immutep Announces Positive Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer Immutep S.A. announced today interim results from its ongoing Phase I/II chemoimmunotherapy clinical trial in metastatic breast carcinoma. ImmuFact IMP321 was administered the day after weekly paclitaxel for six months. The interim results show a clinical response rate of 50 per cent compared to 25 per cent with paclitaxel alone. Study Links Obesity To Elevated Risk Of Ovarian Cancer A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight. FDA Announces Class I Recall Of Ophthalmic Surgical Device The U.S. Food and Drug Administration announced a Class I recall of lot no. UD30654 of Healon D, an ophthalmic viscosurgical device (OVD) manufactured by Advanced Medical Optics Inc. (AMO) of Santa Ana, Calif. OVDs are viscoelastic materials used to maintain space in the eye during surgery. Typically, OVDs are pre-packaged in a syringe and are applied using a small tube. On Oct. FDA Prevents Two Dairies From Adulterating Animal Drugs And Food The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in Clovis, N.M.